00898nas a2200373   4500000000100000008004100001260001300042653001500055653001000070653000900080653002600089653001000115653001200125653003000137653001300167653001100180653002300191653001100214653001200225653000900237653001600246653002500262653001300287653000900300653001700309653001600326653001700342653001700359100001200376245009700388300001800485490000700503022001400510       1973                            d  c1973 Dec10aAdolescent10aAdult10aAged10aAntitubercular Agents10aChild10aDapsone10aDrug Therapy, Combination10aEthiopia10aFemale10aHistocytochemistry10aHumans10aleprosy10aMale10aMiddle Aged10aMycobacterium leprae10aRifampin10aSkin10aSulfonamides10aThalidomide10aTime Factors10aTrimethoprim1 aRohde R00a[Initial clinical results using new, experimentally developed therapeutic forms in leprosy].  aSuppl 1:40-520 v24  a0044-359X